"Osteosarcoma – Pipeline Review, H1 2017-Market Research Report Store＂published in April 2017. It is a professional and in-depth study.

Summary:
Market Research Report Store announces a new report＂Osteosarcoma＂added to its database.Osteosarcoma is the most common cancer of the bone that destroys tissue and weakens the bone. It is developed from immature bone cells that normally form new bone tissue. Symptoms include pain, bone fractures, swelling, redness and limitation of motion of joints. Risk factors include age, gender, family history and Li-Fraumeni syndrome. Treatment includes chemotherapy and surgery.

Report Highlights

The Osteosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Osteosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 14, 7, 9 and 4 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 3, 3, 2 and 4 molecules, respectively.

Osteosarcoma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Complete Report Available at: @
https://www.marketresearchreportstore.com/shop/osteosarcoma-pipeline-review-h1-2017

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Osteosarcoma (Oncology).
– The pipeline guide reviews pipeline therapeutics for Osteosarcoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Osteosarcoma (Oncology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Osteosarcoma (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Osteosarcoma (Oncology)

Reasons to buy

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Osteosarcoma (Oncology).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Osteosarcoma (Oncology) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Request a sample, click here [email protected]

Some points from Table of Contents

Global Markets Direct Report Coverage 6
Osteosarcoma – Overview 7
Osteosarcoma – Therapeutics Development 8
Pipeline Overview 8
Pipeline by Companies 9
Pipeline by Universities/Institutes 12
Products under Development by Companies 13
Products under Development by Universities/Institutes 15
Osteosarcoma – Therapeutics Assessment 16
Assessment by Target 16
Assessment by Mechanism of Action 19
Assessment by Route of Administration 22
Assessment by Molecule Type 24
Osteosarcoma – Companies Involved in Therapeutics Development 26
Advaxis Inc 26
Allosteros Therapeutics Inc 26
Amgen Inc 27
AVEO Pharmaceuticals Inc 27
Bayer AG 28
Bellicum Pharmaceuticals Inc 28
Bristol-Myers Squibb Company 29
Celldex Therapeutics Inc 29
CorMedix Inc 30
CytRx Corp 30
Eisai Co Ltd 31
Eleison Pharmaceuticals LLC 31
Intezyne Technologies Inc 32
Isofol Medical AB 32
Johnson & Johnson 33
MacroGenics Inc 33
MD Biosciences GmbH 34
MediaPharma srl 34
Merck & Co Inc 35
Merck KGaA 35
Merrimack Pharmaceuticals Inc 36
Novartis AG 36
Oncolys BioPharma Inc 37
Pfizer Inc 37
Shionogi & Co Ltd 38
Teijin Pharma Ltd 38
United Therapeutics Corp 39
Osteosarcoma – Drug Profiles 40
3D-QM – Drug Profile 40
3D-QMS – Drug Profile 41
ADXS-HER2 – Drug Profile 42
aldoxorubicin hydrochloride – Drug Profile 46


Contact:
Ann
Sales Manager
Market Research Report Store
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Us
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.